Eden

About Eden

Eden positions itself as a straightforward, affordable GLP-1 telehealth platform with flat upfront pricing and no hidden fees. Founded in 2020, the platform offers one of the broadest medication menus available — both brand-name options (Ozempic, Wegovy, Mounjaro, Zepbound) and compounded alternatives (semaglutide, tirzepatide) — giving patients flexibility across price points.

Monthly pricing ranges from $129 to $329, which is mid-range for the market. Eden differentiates with microdose options — allowing patients to start at lower doses and titrate up gradually, which can reduce side effects and help patients who are hesitant about jumping straight to standard dosing.

With a 4.4 Trustpilot rating across 3,300+ reviews, Eden demonstrates strong patient satisfaction. The review volume and rating combination puts them in the upper tier for reputation, though the lack of a BBB listing means there’s one less external trust signal.

Clinically, Eden falls in the middle. Provider quality is rated medium, and the platform doesn’t include lab testing or dietitian access — both of which are increasingly standard among top-tier competitors. Ongoing support is moderate rather than high, meaning patients who need more hands-on guidance may find the experience lacking.

Trust and compliance transparency is also rated medium, and the CoA status for compounded medications is unknown. For a platform selling compounded GLP-1s, this is a gap worth noting. The fast onboarding and nationwide availability are clear positives, making Eden easy to start with even if the ongoing clinical depth doesn’t match the best in class.

Eden GLP-1 Medications

At a Glance